As we approach the end of the first quarter of 2020, many companies are questioning how to evaluate the impact of COVID-19 on the expected credit outcomes of their financial instruments. The final implementation of IFRS 9 in 2018 means that consideration must be given to whether this represents a significant increase in credit risk, to what extent government actions may mitigate that risk and how this should be reflected in quarter-end reporting. Given the levels of economic uncertainty demonstrated in the public markets and the unknown ultimate impact of COVID-19, using informed judgment to measure potential credit deterioration will require even more thought and analysis.
Please join us for a discussion on how best to consider the impact of COVID-19 for the current quarter-end.
Schedule: 12:00 p.m. - 1:00 p.m. BST
Topics
- What impact will COVID-19 have on the general economic environment?
- Will COVID-19 lead to credit deterioration in the marketplace?
- How can it be determined whether a significant increase in credit risk of the financial instruments has occurred?
- What factors should preparers consider when evaluating the impact of COVID-19 on expected credit losses, in the short-term and long-term?
- How should preparers develop forecasts considering the impact of COVID-19, including the underlying economic and value assumptions utilized in measuring credit deterioration?
Speakers
- Marcus Morton, Managing Director, Valuation Advisory Services
- Ryan McNelley, Managing Director, Portfolio Valuation
- Sharon Davies, Managing Director, Valuation Advisory Services
- Andrew Probert, Managing Director, Transaction Advisory Services
- Jonathan Jacobs, Managing Director, Global Financial Services Leader
To register for the webcast please click here.
